Purpose of review To provide an overview of recent research of how HIV integration relates to productive and latent infection and implications for cure strategies.
INTRODUCTION
Integration of HIV into the host genome is a critical step in the HIV life cycle. Following HIV integration, productive or latent infection can be established. Although productively infected cells have a short half life, latency is established in cells that are long lived or can undergo proliferation [1, 2] . These latently infected cells persist on ART and are the main barrier to an effective cure [3] [4] [5] .
Recently, our understanding of latency has been significantly changed. In productive infection, it was shown many years ago that HIV preferentially integrates into genes [6, 7] and the integration site is heterogenous [8] . In contrast, in CD4þ T-cells from HIV-infected individuals on ART, there is expansion of cells with HIV integration at specific sites or in specific genes [8] [9] [10] . The driver for expansion on ART of cells with specific integration sites, remains a critical unanswered question and could be because of homeostatic proliferation [1] , although this would not explain why one infected cell is favoured over another, antigen-driven expansion or alternatively, a consequence of the site of integration (reviewed in [11] ). For example, the site of integration may render a cell less susceptible to apoptosis or increase the likelihood of clonal expansion.
One of the major controversies has been whether proliferation of infected cells with a specific integration site was possible with an intact rather than a defective virus. A defective provirus is defined by the presence of inversions, hypermutation, premature stop-codons, large internal deletions, frameshift mutation, packaging signal mutation or mutations in the major splice donor site [12
One of the earlier studies of integration sites in CD4þ T-cells from individuals on ART demonstrated that all clonally expanded cells harboured defective provirus [8] . A subsequent study analysing cells from an HIVinfected individual on ART with malignancy, intact virus was sequenced from a specific clone and fulllength construction of this virus clearly showed the virus was replication competent [14] . Subsequently, other groups sequenced RNA from supernatants collected in viral outgrowth assays (VOA) using CD4þ T cells from HIV-infected individuals on ART and demonstrated that the majority of intact replication competent virus was derived from clonally expanded cells [ 19] . In a recent case study of an HIV-infected individual on ART with an exceptionally high frequency of cells with integrated HIV (31 070 per million CD4þ T cells), which was several logs higher than the frequency of cells with replication competent virus as measured by a modified Quantitative Viral Outgrowth Assay (mQVOA) or Tat/rev Induced Limiting Dilution Assay (TILDA), the vast majority of integrated virus was defective [20] . Single-genome sequencing of the viral envelope revealed a unique sequence and integration site sequencing demonstrated that 83% of effector memory cells contained virus integrated in chromosome 14, in the Ribosomal Protein S6 Kinase A5 (RPS6KA5) gene [20] required for stress-induced phosphorylation of transcription factors [21] .
Insights into the kinetics of clonally expanded, latently infected cells on ART can be determined using site-directed PCR, rather than sequencing. Using a multiplex droplet digital PCR that quantified proviral DNA with separate primers in the LTR, gag, tat/rev exons 1 and 2, the LTR:Gag ratio increased after a median of 14.4 years on ART, consistent with an increase in defective virus [22] . In this study, one integration site, which represented 20% of the total integration sites, was located in the HORMA Domain Containing 2 (HORMAD2) gene, essential for synapsis surveillance during meiosis and known to be defective [22] . This clone was detected after 6 months on ART and the expansion over time of this clone, suggests a survival advantage or some other form of selection [22] . One explanation could be that cells that contain replication competent virus, or express viral proteins are preferentially lost over time, potentially because of immune recognition and therefore, virus with large internal deletions will increase over time [23 && ]. Although defective viruses are not able to replicate upon cessation of ART, defective provirus may still be transcriptionally active and produce viral proteins [23 && ,24,25] . In another case study of an HIV-infected individual on ART, direct amplicon
KEY POINTS
Identical integration sites in CD4þ T-cells from HIVinfected individuals on ART is consistent with proliferation being a major driver of HIV persistence on ART.
Defective provirus can produce HIV RNA, viral protein and contributes to chronic immune activation.
HIV transcription levels differs in clonally expanded cells with the same integration sites.
Integration sites in SIV-infected rhesus macaques demonstrate a similar pattern as integration site patterns in humans.
Inhibition of LEDGF/p75 results in HIV integration patterns resembling a pattern consistent with latency.
sequencing of the genomic DNA revealed a dominant clone with a 2.4 kb deletion leaving Gag, Pol and Nef intact [25] . This partially deleted provirus could still produce Gag and Nef proteins as detected by western blot and flow cytometry [25] . Persistent antigen presentation could potentially drive chronic immune activation and CD8þ T-cell exhaustion, as shown recently [23 && ] . Together these data demonstrate that defective proviruses accumulate during ART, and although not replication competent, these defective viruses can still produce HIV proteins, and potentially contribute to adverse outcomes ( Fig. 1) . Therefore, we might not be able to completely ignore defective viruses that persist on ART.
Intact viruses and clonal expansion
Over the last 12 months, multiple groups have now clearly demonstrated that expanded clones of infected cells on ART, can also contain intact virus, which is replication competent [14, 15 && ,16 & ,17]. In one individual with a squamous cell carcinoma, a single infected clone with intact replication competent virus accounted for 4% of the total number of infected cells [9, 14] . Using single cell RNA sequencing, they showed that a fraction of these clones could express HIV RNA whereas the majority more than 95% remained latently infected [26 & ].
Interestingly, these clones of intact and defective infected cells had a similar level of expression of cellassociated HIV RNA [26 & ]. Another way to determine the relationship of HIV RNA expression to integration sites or clonal expansion, is to assess individuals with drugresistant virus [27] . In a recent longitudinal study of individuals on ART infected with drug-resistant and wild-type virus, 4.5% of cells infected with wild type virus expressed cell-associated HIV RNA at low levels, whereas almost 20% of cells infected with drug-resistant provirus expressed high levels of cellassociated HIV RNA, potentially representing recent infection of these cells [27] . This data also shows that some clonally expanded cells with replication competent viruses can produce virus whereas other infected cells remain latent (Fig. 1) . Additionally, the study demonstrated that the chromatin environment surrounding the same integration site in clonally expanded cells can differ, which will lead to different outcomes for the infected cell.
Using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis [28] we recently demonstrated using CD4þ T cells from HIV-infected individuals on ART, that integration sites in clonally expanded cells were in pathways associated with evasion of apoptosis and cell proliferation [29] . Further studies are still needed to show a direct link between the site of HIV integration and an effect on proliferation or cell survival and thereby likelihood of clonal expansion.
MODELS FOR STUDYING HIV INTEGRATION SITES AND IMPACT ON TRANSCRIPTION
The chromatin environment surrounding an HIV integration site critically determines how much HIV RNA is expressed. For example, an increase in histone acetylation or a reduction in methylation will result in an increase in HIV transcription [30, 31] . Modification of the chromatin environment with latency reversing agents (LRA) is one approach being investigated to eliminate latency [32] [33] [34] . Therefore, response of latently infected cells to an LRA may be directly related to the site of HIV integration.
Using an adapted dual fluorescent reporter virus [with confirmation sensitive Green Fluorescent Protein, (csGFP)] expression following productive infection and monomeric Kusabira-Orange (mKO) fluorescent protein following integration, both latent and productive infection can be quantified in vitro [35] . In some latently infected cells, virus could be activated to express GFP with a stimulus such as anti-CD3/anti-CD28 or an LRA [32, 36, 37] (inducible latency), whereas in other cells, there was HIV integration but csGFP expression was not observed (noninducible latency) [38] . In this model, noninduced latent viruses were found more commonly in intergenic regions and further away from activation enhancers and active transcribed regions [39 && ]. Interestingly, noninduced viruses compared with productive infection were more frequently located in lamin-associated domains (LADs) [39 && ]. Furthermore, HIV can be integrated in the same gene, referred to as recurrent integrated genes (RIG) and these are usually outside LADs [7] .
In a separate model system, in response to the histone deacetylase inhibitor (HDACi) vorinostat, an LRA with low potency, only 5% of cells produced a marker of productive infection marker, consistent with insufficient HIV RNA transcription and/or HIV protein production, as previously described [32,40 & ,41]. It is possible that the absence of Nef in the reporter viruses used in these models may be relevant and lead to reduced virus expression. Following the removal of Nef, using Clustered Regularly Short Palindromic Repeats/CRISPR-associated system 9 (CRISPR/Cas9) in a T-cell line [42] infected with envelope deleted fluorescent reporter HIV, there was a reduction in fluorescent reporter protein after activation with LRAs [43] .
Another approach used CRISPR/Cas9 to introduce an HIV-derived reporter cassette in a known integration site. In this study, the investigators introduced HIV in a T-cell line, at two sites in the BACH2 gene at intron 5, a well described RIG [9] . Integration at these sites led to the production of the reporter protein after LRA administration [44] . The utilization of CRISPR/Cas9 to knock in an HIV reporter construct at a particular position in the human genome opens the possibility of investigating the functional impact of a clonally expanded specific integration site.
ASSESSMENT OF INTEGRATION SITES USING HUMAN TISSUE AND ANIMAL MODELS
Studying HIV integration in latently infected cells in vitro, using cell lines or primary CD4þ T cells, does not necessarily recapitulate what happens in vivo, where there are multiple other factors driving HIV persistence including proliferation and the location of infected cells in tissue [29,45,46 & ]. In matched blood and rectal tissue samples from two HIVinfected individuals on ART, we observed that clonal expansion of CD4þ T cells as measured by identical HIV integration sites was lower in rectal tissues compared with blood [29] . Further work is needed in matched blood and tissue samples from HIVinfected individuals on ART, to determine whether the driver for clonal expansion is site-specific.
Similar to studies in HIV-infected individuals on ART [8-10,29], in Simian immunodeficiency virus (SIV)-infected rhesus macaques on suppressive ART, SIV was integrated in highly transcribed genes and gene-rich regions with evidence of clonal expansion [47] . In contrast to human studies where access to tissue is limited, here multiple compartments were examined including blood, lymph node and spleen. Similar levels of clonal expansion of cells with identical integration sites were found in two or more different sites [47] . The similarity of HIV integration patterns in rhesus macaques and human studies is an important finding and will hopefully allow for a far more extensive understanding of factors driving clonal expansion in tissues, including the central nervous system.
HOST FACTOR CONTROL OF HIV INTEGRATION
It is now apparent that interactions of the virus with specific host proteins will influence the site of HIV integration. Specifically, microtubules, the nuclear pore proteins and host proteins such as Lens Epithelium-Derived Growth Factor (LEDGF) can determine where HIV integrates, which in turn can determine the transcriptional activity of the integrated provirus and the likelihood of latent or productive infection.
HIV ENTRY INTO THE NUCLEUS
After HIV binds to the CD4 receptor and chemokine co-receptor on the target cell, the viral capsid is released into the cytoplasm. The HIV capsid traffics to the nuclear pore through interaction with microtubules [48] [49] [50] . Dharan et al. [51] demonstrated that a microtubular adaptor protein bicaudual D homolog 2 (BICD2) binds the HIV capsid. CRISPR/ Cas9 knock-out of BICD2 showed that movement of the viral core to the nucleus was disrupted and postulated that this interaction would be a novel therapeutic target to inhibit integration (Fig. 2) [51] .
If normal trafficking of HIV to the nucleus occurs, the viral capsid docks with the nuclear pore complex through the nuclear pore protein Nucleoporin (Nup)98/Ran Binding Protein (BP) 2. Subsequently, Nup153 and Nup98 interact with the viral preintegration complex (PIC) and transport the HIV genome across an intact nuclear membrane [52] [53] [54] . Nup153 is thought to interact with the PIC and anchors itself to Translocated Promoter Region (TPR), a nuclear basket protein [55] . One important function of TPR is exclusion of heterochromatin near the nuclear pore and it is thought that TPR recruits highly transcribed genes to the immediate proximity of the nuclear pore [56] . Knock down of TPR by short hairpin RNA (shRNA) in a T-cell line demonstrated that HIV integration occurred more distal from H3K36me3 chromatin marks, which are associated with actively transcribed genes [57] . Additionally, knockdown of TPR led to HIV integration in genes involved in in cell cycle, DNA repair and transcription [58] (Fig. 2) .
HOST FACTORS GUIDING HIV INTEGRATION TO ACTIVE TRANSCRIPTIONAL SITES
Beyond the nuclear pore proteins, there are other host proteins that are critically important for HIV integration, one of the most important being, LEDGF/p75 [59] . LEDGF/p75 interacts with the PIC by binding HIV integrase at one end and host chromatin at the other end, to tether the PIC to the target host genome [60] . LEDGF/p75 targets vesicular stomatitis virus protein G (VSV-G) pseudotyped HIV, in HEK293T cells, to intron-dense, highly spliced genes that are transcribed by RNA polymerase II [61] , which has been proven to be a co-factor in HIV integration [62, 63] .
The Facilitates Chromatin Transcription (FACT) complex was recently shown to bind to LEDGF/p75 [64] . FACT concentrates in the vicinity of HIV integrationsitesandRNApolymeraseIIinvitro (Fig.2) [63] .Itis thought that FACT remodels the chromatin structure generating partially dissociated nucleosomes leading to chromatin structures that favour both RNA transcription and HIV integration [63] .
Inhibition of the interaction between LEDGF/ p75 and HIV integrase with compounds called LEDGINS strongly inhibits infectivity of HIV in vitro [65] . However, LEDGINs also changed the patterns of HIV integration to sites more distal from epigenetic markers associated with transcription [66, 67] . Interestingly, HIV infection in the presence of LEDGIN reduced the response of the infected cell to LRAs [67] .
In summary, it is now clear that multiple host proteins can guide HIV integration to a specific site. In turn, these sites may enhance or inhibit HIV transcription, therefore, having a significant effect on latency or the response to an LRA. Given that latency is established within days of infection, it remains unclear whether targeting these early events will translate into an effective intervention to eliminate latently infected cells.
CONCLUSIONS AND IMPLICATIONS
In conclusion, over the past 12 months, our understanding of the features of HIV integration in latently infected cells has advanced significantly. First, it is now clear that expanded clones of infected cells with identical integration sites can harbour both intact and defective viruses. Second, the location of integration influences basal and inducible transcription, which has significant implications for activity of LRAs. Finally, multiple host proteins determine the site of integration and could be potential new targets to inhibit the establishment of latency.
Clonal expansion of infected cells that harbour intact replication competent viruses are a major challenge for strategies aimed at eliminating latency [26 & ,39 && ]. It will be critical to understand the drivers for expansion in order to develop a targeted intervention [9, 10, 29, 44] . One potential approach to inhibit proliferation of infected clones could be the inhibition of Janus Kinase I (JAK-I), which was shown to inhibit seeding of the viral reservoir and blocked proliferation of infected cells resulting in a reduction of infected cells in vitro [68] . Whether this will translate to in-vivo efficacy remains to be determined. New interventions could also be developed to inhibit protein expression from clonally expanded cells infected with a defective virus [23 && ,24,25,69 & ] as a potential strategy to reduce chronic immune activation, which is detrimental for individuals living with HIV [70] . Inhibition of tat-induced transcription could inhibit production of replication competent and defective viral RNA thereby reducing HIV antigen presentation [71] .
Finally, a detailed understanding of all the events that lead to HIV integration could identify new targets for interventions, which may be important if there is ongoing infection of cells on ART [72, 73] .
In summary, we have learnt that far more mechanistic studies are needed to understand HIV integration, HIV transcription and clonal expansion of infected cells in individuals on ART. Insights from Tcell biologists who understand the fundamental drivers for T-cell memory and homeostasis may prove to be helpful. Furthermore, the availability and application of new bioinformatic tools, single cell sequencing, CRISP/Cas9 libraries, dual reporter viruses and robust animal models will likely accelerate our understanding of HIV persistence on ART and lead to new interventions.
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